CGFI
NTUS

Cypress Growth Fund III’s Natus Medical Inc NTUS Stock Holding History

Cypress Growth Fund III’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.76M Hold
70,000
– – 1.48% 29
2021
Q2 		$1.82M Hold
70,000
– – 1.52% 28
2021
Q1 		$1.79M Sell
70,000
-5,000
-7% -$128K 1.55% 30
2020
Q4 		$1.5M Buy
+75,000
New +$1.47M 1.29% 30

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cypress Growth Fund III's NTUS Position: Q3 2021 in Review

Cypress Growth Fund III held its Natus Medical Inc (NTUS) position steady in Q3 2021 at 70,000 shares worth $1.76M. The position accounts for 1.48% of the portfolio, ranked #29.

Cypress Growth Fund III first reported a position in NTUS in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.82M in Q2 2021. 169 funds tracked by Wall St. Rank hold NTUS as of Q3 2021.

  • Cypress Growth Fund III held 70,000 shares of Natus Medical Inc worth $1.76M as of Q3 2021.
  • Cypress Growth Fund III left its Natus Medical Inc share count unchanged in Q3 2021.
  • Natus Medical Inc made up 1.48% of Cypress Growth Fund III's portfolio in Q3 2021, its #29 holding.
  • Cypress Growth Fund III first reported a position in Natus Medical Inc in Q4 2020 and has held it in 4 quarters since.
  • Cypress Growth Fund III's Natus Medical Inc position peaked at $1.82M in Q2 2021.
  • 169 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2021.

Based on Cypress Growth Fund III's 13F filing for Q3 2021, filed 26 Oct 2021.